Related references
Note: Only part of the references are listed.High molecular weight amyloid β1-42 oligomers induce neurotoxicity via plasma membrane damage
Taro Yasumoto et al.
FASEB JOURNAL (2019)
Elevated levels of Secreted-Frizzled-Related-Protein 1 contribute to Alzheimer's disease pathogenesis
Pilar Esteve et al.
NATURE NEUROSCIENCE (2019)
Lipid Membranes Influence the Ability of Small Molecules To Inhibit Huntingtin Fibrillization
Maryssa Beasley et al.
BIOCHEMISTRY (2019)
Insights into the inhibitory mechanism of a resveratrol and clioquinol hybrid against Aβ42 aggregation and protofibril destabilization: A molecular dynamics simulation study
Rajneet Kaur Saini et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2019)
Alpha-synuclein stepwise aggregation reveals features of an early onset mutation in Parkinson's disease
Guilherme A. P. de Oliveira et al.
COMMUNICATIONS BIOLOGY (2019)
Alzheimer's disease as oligomeropathy
Kenjiro Ono
NEUROCHEMISTRY INTERNATIONAL (2018)
The Amyloid-beta Oligomer Hypothesis: Beginning of the Third Decade
Erika N. Cline et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
The A beta protofibril selective antibody mAb158 prevents accumulation of A beta in astrocytes and rescues neurons from A beta-induced cell death
Sofia Sollvander et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Alzheimer's disease research: the future of BACE inhibitors
Talha Burki
LANCET (2018)
Sub-angstrom cryo-EM structure of a prion protofibril reveals a polar clasp
Marcus Gallagher-Jones et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2018)
Trial of Solanezumab for Mild Dementia Due to Alzheimer's Disease
Lawrence S. Honig et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Dihydrochalcone molecules destabilize Alzheimer's amyloid- protofibrils through binding to the protofibril cavity
Yibo Jin et al.
PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2018)
Origin of metastable oligomers and their effects on amyloid fibril self- assembly
Filip Hasecke et al.
CHEMICAL SCIENCE (2018)
Sub-angstrom cryo-EM structure of a prion protofibril reveals a polar clasp
Marcus Gallagher-Jones et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2018)
Efficient clearence of Aβ protofibrils in AβPP-transgenic mice treated with a brain-penetrating bifunctional antibody
Stina Syvanen et al.
ALZHEIMERS RESEARCH & THERAPY (2018)
Promising Results in 18-Month Analysis of Alzheimer Drug Candidate
Jennifer Abbasi
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Ion Channel Formation by Amyloid-β42 Oligomers but Not Amyloid-β40 in Cellular Membranes
David C. Bode et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Changes in lipid membranes may trigger amyloid toxicity in Alzheimer's disease
Elizabeth Drolle et al.
PLOS ONE (2017)
Calcium Hypothesis of Alzheimer's disease and brain aging: A framework for integrating new evidence into a comprehensive theory of pathogenesis
Ottavio Arancio et al.
ALZHEIMERS & DEMENTIA (2017)
Why has therapy development for dementia failed in the last two decades?
Serge Gauthier et al.
ALZHEIMERS & DEMENTIA (2016)
Amyloid-β42 protofibrils are internalized by microglia more extensively than monomers
Lisa K. Gouwens et al.
BRAIN RESEARCH (2016)
The amyloid hypothesis of Alzheimer's disease at 25years
Dennis J. Selkoe et al.
EMBO MOLECULAR MEDICINE (2016)
Accumulation of amyloid-β by astrocytes result in enlarged endosomes and microvesicle-induced apoptosis of neurons
Sofia Sollvander et al.
MOLECULAR NEURODEGENERATION (2016)
The antibody aducanumab reduces Aβ plaques in Alzheimer's disease
Jeff Sevigny et al.
NATURE (2016)
High-speed atomic force microscopy reveals structural dynamics of amyloid β1-42 aggregates
Takahiro Watanabe-Nakayama et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Drug development in Alzheimer's disease: the path to 2025
Jeffrey Cummings et al.
ALZHEIMERS RESEARCH & THERAPY (2016)
Bapineuzumab for mild to moderate Alzheimer's disease in two global, randomized, phase 3 trials
Rik Vandenberghe et al.
ALZHEIMERS RESEARCH & THERAPY (2016)
Safety and tolerability of BAN2401-a clinical study in Alzheimer's disease with a protofibril selective Aβ antibody
Veronika Logovinsky et al.
ALZHEIMERS RESEARCH & THERAPY (2016)
Role of Apolipoprotein E in β-Amyloidogenesis ISOFORM-SPECIFIC EFFECTS ON PROTOFIBRIL TO FIBRIL CONVERSION OF Aβ IN VITRO AND BRAIN Aβ DEPOSITION IN VIVO
Yukiko Hori et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Destabilization of Alzheimer's Aβ42 Protofibrils with a Novel Drug Candidate wgx-50 by Molecular Dynamics Simulations
Huai-Meng Fan et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2015)
Considerably Unfolded Transthyretin Monomers Preceed and Exchange with Dynamically Structured Amyloid Protofibrils
Minna Groenning et al.
SCIENTIFIC REPORTS (2015)
The Murine Version of BAN2401 (mAb158) Selectively Reduces Amyloid-beta Protofibrils in Brain and Cerebrospinal Fluid of tg-ArcSwe Mice
Stina Tucker et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Amyloid-β(1-42) protofibrils stimulate a quantum of secreted IL-1β despite significant intracellular IL-1β accumulation in microglia
Shana E. Terrill-Usery et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)
Oxidative Stress in Alzheimer's Disease: Are We Connecting the Dots?
Michela Rosini et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Interactions of a Water-Soluble Fullerene Derivative with Amyloid-β Protofibrils: Dynamics, Binding Mechanism, and the Resulting SaltBridge Disruption
Xiaoying Zhou et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2014)
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
Stephen Salloway et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Perspectives on future Alzheimer therapies: amyloid-beta protofibrils - a new target for immunotherapy with BAN2401 in Alzheimer's disease
Lars Lannfelt et al.
ALZHEIMERS RESEARCH & THERAPY (2014)
The formation of tau pore-like structures is prevalent and cell specific: possible implications for the disease phenotypes
Cristian A. Lasagna-Reeves et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2014)
Alzheimer´s Disease and Oxidative Stress: A Review
Miroslav Pohanka
CURRENT MEDICINAL CHEMISTRY (2013)
A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease
Rachelle S. Doody et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Isolated Amyloid-β(1-42) Protofibrils, But Not Isolated Fibrils, Are Robust Stimulators of Microglia
Geeta S. Paranjape et al.
ACS CHEMICAL NEUROSCIENCE (2012)
Large Aggregates Are the Major Soluble Ab Species in AD Brain Fractionated with Density Gradient Ultracentrifugation
Dag Sehlin et al.
PLOS ONE (2012)
Amyloid-β Peptide Binds to Cytochrome C Oxidase Subunit 1
Luis Fernando Hernandez-Zimbron et al.
PLOS ONE (2012)
Reactive Oxygen Species in the Regulation of Synaptic Plasticity and Memory
Cynthia A. Massaad et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
Heavy-Chain Complementarity-Determining Regions Determine Conformation Selectivity of Anti-A beta Antibodies
Dag Sehlin et al.
NEURODEGENERATIVE DISEASES (2011)
Oxidative Stress in the Progression of Alzheimer Disease in the Frontal Cortex
Mubeen A. Ansari et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2010)
The Disintegrin/Metalloproteinase ADAM10 Is Essential for the Establishment of the Brain Cortex
Ellen Jorissen et al.
JOURNAL OF NEUROSCIENCE (2010)
Amyloid-β protofibril levels correlate with spatial learning in Arctic Alzheimer's disease transgenic mice
Anna Lord et al.
FEBS JOURNAL (2009)
An amyloid-β protofibril-selective antibody prevents amyloid formation in a mouse model of Alzheimer's disease
Anna Lord et al.
NEUROBIOLOGY OF DISEASE (2009)
Structure-neurotoxicity relationships of amyloid β-protein oligomers
Kenjiro Ono et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Effects of Grape Seed-derived Polyphenols on Amyloid β-Protein Self-assembly and Cytotoxicity
Kenjiro Ono et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Grape-derived polyphenolics prevent Aβ oligomerization and attenuate cognitive deterioration in a mouse model of Alzheimer's disease
Jun Wang et al.
JOURNAL OF NEUROSCIENCE (2008)
Sensitive ELISA detection of amyloid-β protofibrils in biological samples
Hillevi Englund et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Intracellular Aβ and cognitive deficits precede β-amyloid deposition in transgenic arcAβ mice
Marlen Knobloch et al.
NEUROBIOLOGY OF AGING (2007)
Polymorphism in the intermediates and products of amyloid assembly
Ravindra Kodali et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2007)
Docosahexaenoic acid stabilizes soluble amyloid-β protofibrils and sustains amyloid-β-induced neurotoxicity in vitro
Ann-Sofi Johansson et al.
FEBS JOURNAL (2007)
Physiochemical characterization of the Alzheimer's disease-related peptides Aβ1-42Arctic and Aβ1-42wt
Ann-Sofi Johansson et al.
FEBS JOURNAL (2006)
The Arctic Alzheimer mutation facilitates early intraneuronal A beta aggregation and senile plaque formation in transgenic mice
A Lord et al.
NEUROBIOLOGY OF AGING (2006)
Inhibition of phospholipase A2 activity reduces membrane fluidity in rat hippocampus
EL Schaeffer et al.
JOURNAL OF NEURAL TRANSMISSION (2005)
Soluble Arctic amyloid β protein inhibits hippocampal long-term potentiation in vivo
I Klyubin et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
α-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils
HA Lashuel et al.
JOURNAL OF MOLECULAR BIOLOGY (2002)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation
C Nilsberth et al.
NATURE NEUROSCIENCE (2001)
Share Paper
